Boston Scientific experiences global operational disruptions, including to its order processing and shipping systems, after detecting a cyberattack on August 25, 2026. While the medical device maker investigates the incident alongside third-party specialists, its shares fall 5% in premarket trading. The attack follows a pattern of recent breaches targeting healthcare firms like Stryker and Abbott Laboratories. Analysts estimate a potential 600 to 700 basis-point impact on Boston Scientific's third-quarter revenue if recovery takes three weeks.
Story comments
Loading comments…